Important Announcement: Journal status update, Garuda indexation, and the separation of OJS systems.
Mei Syafriadi
Laboratorium Patologi, Bagian Biomedik, Fakultas Kedokteran gigi Universitas Jember
DOI:
Keywords: oncogenes, onco-suppressor genes, pathogenesis, carcinoma
ABSTRACT
The purposes of this study are to study the pathogenesis of oral cancer and to see the role play of oncogenes, onco-suppressor genes in cancer growth and their mutation type. There are many predisposing factors which may influence the development of cancer. The factors are divided intrinsic (hereditary) and extrinsic factors (bacteria, viruses, fungi, chemical, drugs, radiation, trauma, heat, cold and nutrition). These agents may act individually, in combination with other carcinogen (co-carcinogen) or in combination with other agents that do not in themselves causes cancer (promoters), but that help the carcinogens to mutate or depress cells, but in the mechanism still enigma. Oncogenes onco-suppressor genes are normal genes in human. Oncogenes functions are as growth factor (e.g. sis), growth factor receptor (e.g. erbB1), signal transducer (e.g. ras) or nuclear factor (e.g. myc, jun). Tumor (oral cancer) will be arises if oncogenes and onco-suppressor genes function are disturbed by some carcinogen and these genes have mutation, deletion, amplification or translocation. That was also related to the loss or inactivation of onco-suppressor genes such as p53, so that causes the loss of the normal growth regulation/strait control that associated with tumorigenesis.
REFERENCES
Ash MM, Ward ML. Neoplasm. In Oral Pathology, An Introduction to General and Oral Pathology for Hygienist, 6th edn. Lea and Febringer, Philadelphia, 1992; 126-43.
Cruz IB, Snijders PJ, Van Houten V, Vosjan M, Van der Waal I, Meijer CJ. Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas. J Clin Pathol. 2002; 55: 834-40.
Gould AR.. "Oral Cancer". In Burkett's Oral Medicine, Diagnosis and Treatment. 9th (Lynch, MA. Ed). Philadelphia. JB. Lippincott Company. 1995; 203-34.
Hockenberry D. Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondria membrane protein that blocks programmed cell death. Nature. 1990; 348:334-6.
Malcolm S. Oncogene in Malignancy. Arch Disease Child. 1988; 63: 1099-103.
Miller R1.. Neoplastic cell growth. In General and Oral Pathology for the Dental Hygienist. (eds Duncan L. and Salway J); Mosby-Year Book Incorporated. Missouri, 1995; 87.
Nowell PC and Croce CM. Chromosomes, genes and cancer. Am J Phatol. 1986; 125:8-15.
Quirke P and Cawkwell L. Molecular genetics of cancer. Quoted in: Recent Advances in Histology (eds. Anthony PP and MacSween RNM); Churchill Livingstone. London, 1994; 1-20.
Regezi JA, Sciubba JJ. Ulcerative condition. In Oral Pathology. (Regezi JA and Sciubba JJ. Ed.); W.B Saunders Company. London, 1989; 68-110.
Reksoprawiro S. Surgery in locally advanced oral cancer. Proceeding. Indonesian Oral and Maxillofacial Association Meeting, 2008; Denpasar, Bali.
Saku T. Differential diagnosis of oral mucosal lesions. Proceeding. The 3th National Dental Scintific Meeting, 2008; Faculty of Dentistry, Jember University.
Saranath D. Panchal RG, Nair R, Mehta RA, Sanghavi V, Sumegi J, Klein G, Geo GM. Oncogene amplification in squamous cell carcinoma of the oral cavity. Cancer Res J. 1989; 80:430-37
Scully C. Oncogeneses, Onco-suppressors, carcinogenesis and oral cancer. Br Dent J. 1992; 173:53-9.
Smith, C. J. Epidemiology and Aetiology. In Malignant Tumours of the Mouth, Jaws & Salivary Glands. (Langdon, J. D. and J. M. Henk. Eds.). Boston: Brown and Company, 1995; 1-13.
Syafriadi M, Saku T. p53-protein over-expression and gene mutational of oral carcinoma in-situ. Dental Journal, 2007; 40:2, 55-60.
Syafriadi M. Manifestation, treatment modalities and prognosis of oral cancer at the Faculty of Dentistry, University of Malaya from 1980-1995. Thesis. 1998; Kuala Lumpur. Malaysia.
Takita K, Sato T, Miyagi M. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res J 1992, 52: 394-17
Weinberg RA. Oncogenes, anti-oncogenes and the molecular bases of multi step carcinogenesis. Cancer Res J. 1989, 49: 3713-21.